Welcome to OncoGeneX OncoGenex Pharmaceuticals Inc
OVERVIEW
ONCOGENEX.COM TRAFFIC
Date Range
Date Range
Date Range
ONCOGENEX.COM HISTORY
SPAN
LINKS TO WEBSITE
Invests in a broad range of healthcare companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs more. Thu, Jan 25th, 2018. Tue, Jan 9th, 2018.
OncoGenex Second Quarter 2016 Conference Call. OncoGenex ENSPIRIT Trial Conference Call. Exploring New Compounds to Meet the Challenge of Cancer Treatment Resistance. Phase 2 in bladder, lung, pancreatic and prostate cancers. Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals.
SPUD - Outsourced HR and Recruiting. Buzzbee Technology Marketing - Recruiting. Immune Design - Outsourced HR and Recruiting. Resourceful HR provides Immune Design with the HR and recruiting services needed to grow and innovate in Seattle and Bay Area. Project Consulting? Welcome to Resourceful HR! Ndash; Save time in the areas you need it most. You can choose from all or some of our services including candidate sourcing and recommendations based on your bud.
Looking to Deliver More Value from Your Social Campaigns? Cision Has Raised the Bar. Experience summer in Mont Tremblant with Porter Airlines.
SPUD - Outsourced HR and Recruiting. Buzzbee Technology Marketing - Recruiting. Immune Design - Outsourced HR and Recruiting. Resourceful HR provides Immune Design with the HR and recruiting services needed to grow and innovate in Seattle and Bay Area. Respect in the Workplace Training. Project Consulting? Please sign up for our newsletter. Welcome to Resourceful HR! Ndash; Save time .
WHAT DOES ONCOGENEX.COM LOOK LIKE?
CONTACTS
ONCOGENEX TECHNOLOGIES INC.
SUSAN TEES
SUITE 401 1001 WEST BROADWAY
VANCOUVER, BC, V6H 4B1
CA
ONCOGENEX TECHNOLOGIES INC.
KEVIN NOUWENS
1522 217TH PL SE
BOTHELL, WA, 98021
US
ONCOGENEX.COM SERVER
NAME SERVERS
SERVER SOFTWARE AND ENCODING
We caught that this domain is employing the nginx operating system.SITE TITLE
Welcome to OncoGeneX OncoGenex Pharmaceuticals IncDESCRIPTION
Scientific Publications and Presentations. Scientific Publications and Events. Treatment failure attributed to resistance is a major problem in medical oncology. Across tumor types, the majority of patients with cancer are likely to face treatment resistance at some point. Thursday, Jul 30 2015. OncoGenex to Report Second Quarter 2015 Financial Results on August 13, 2015. Monday, Jul 13 2015. Wednesday, Jun 10 2015. FDA Agrees with OncoGenex Phase 3 AFFINITY Protocol Amendment. See More Recent News.PARSED CONTENT
The web page oncogenex.com has the following in the web page, "Treatment failure attributed to resistance is a major problem in medical oncology." I viewed that the webpage also stated " Across tumor types, the majority of patients with cancer are likely to face treatment resistance at some point." They also said " Thursday, Jul 30 2015. OncoGenex to Report Second Quarter 2015 Financial Results on August 13, 2015. Monday, Jul 13 2015. Wednesday, Jun 10 2015. FDA Agrees with OncoGenex Phase 3 AFFINITY Protocol Amendment."SEE SUBSEQUENT DOMAINS
Cancer treatment and prevention supplement. How oncogen XP-180, a all natural probiotic supplement can treat and prevent certain cancer. And how you can help others in your country. Tuesday, August 01, 2006. What is Oncogen XP-180? For more info please contact me or post a comment here. In vitro anti-cancer activity of a novel microbial fermentation product on human carcinomas.
Welcome to Your New Wiki! Click on the edit button above to put your own content on this page. To invite new members, click on Settings. To set who can view and edit your wiki, click on Settings. Click on the help link above to learn more about how to use your wiki. Help on how to format text.
Corpo do útero e do endométrio. Quinta-feira, 1 de fevereiro de 2007. A sub-especialidade oncologia - ginecológica tem, nas últimas décadas, apresentado um desenvolvimento científico significativo, tornando patente que o cuidado com a mulher deve ser feito por uma equipe multidisciplinar. O suporte técnico-científico de forma abrangente principalmente às mulhere.
Quinta-feira, 1 de fevereiro de 2007. A sub-especialidade oncologia - ginecológica tem, nas últimas décadas, apresentado um desenvolvimento científico significativo, tornando patente que o cuidado com a mulher deve ser feito por uma equipe multidisciplinar. O suporte técnico-científico de forma abrangente principalmente às mulheres, .